These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11792458)

  • 1. Evidence supporting a role for N-acetyl-L-aspartate as a molecular water pump in myelinated neurons in the central nervous system. An analytical review.
    Baslow MH
    Neurochem Int; 2002 Apr; 40(4):295-300. PubMed ID: 11792458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-acetylaspartate in the vertebrate brain: metabolism and function.
    Baslow MH
    Neurochem Res; 2003 Jun; 28(6):941-53. PubMed ID: 12718449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain N-acetylaspartate as a molecular water pump and its role in the etiology of Canavan disease: a mechanistic explanation.
    Baslow MH
    J Mol Neurosci; 2003; 21(3):185-90. PubMed ID: 14645985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of aspartoacylase activity in cultured rat macroglial cells is limited to oligodendrocytes.
    Baslow MH; Suckow RF; Sapirstein V; Hungund BL
    J Mol Neurosci; 1999; 13(1-2):47-53. PubMed ID: 10691291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uncoupling N-acetylaspartate from brain pathology: implications for Canavan disease gene therapy.
    von Jonquieres G; Spencer ZHT; Rowlands BD; Klugmann CB; Bongers A; Harasta AE; Parley KE; Cederholm J; Teahan O; Pickford R; Delerue F; Ittner LM; Fröhlich D; McLean CA; Don AS; Schneider M; Housley GD; Rae CD; Klugmann M
    Acta Neuropathol; 2018 Jan; 135(1):95-113. PubMed ID: 29116375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canavan disease. Analysis of the nature of the metabolic lesions responsible for development of the observed clinical symptoms.
    Baslow MH; Resnik TR
    J Mol Neurosci; 1997 Oct; 9(2):109-25. PubMed ID: 9407392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppressing N-Acetyl-l-Aspartate Synthesis Prevents Loss of Neurons in a Murine Model of Canavan Leukodystrophy.
    Sohn J; Bannerman P; Guo F; Burns T; Miers L; Croteau C; Singhal NK; McDonough JA; Pleasure D
    J Neurosci; 2017 Jan; 37(2):413-421. PubMed ID: 28077719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Acetylaspartate in the CNS: from neurodiagnostics to neurobiology.
    Moffett JR; Ross B; Arun P; Madhavarao CN; Namboodiri AM
    Prog Neurobiol; 2007 Feb; 81(2):89-131. PubMed ID: 17275978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Canavan's spongiform leukodystrophy: a clinical anatomy of a genetic metabolic CNS disease.
    Baslow MH
    J Mol Neurosci; 2000 Oct; 15(2):61-9. PubMed ID: 11220786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-acetylaspartate supports the energetic demands of developmental myelination via oligodendroglial aspartoacylase.
    Francis JS; Wojtas I; Markov V; Gray SJ; McCown TJ; Samulski RJ; Bilaniuk LT; Wang DJ; De Vivo DC; Janson CG; Leone P
    Neurobiol Dis; 2016 Dec; 96():323-334. PubMed ID: 27717881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct determination of the N-acetyl-L-aspartate synthesis rate in the human brain by (13)C MRS and [1-(13)C]glucose infusion.
    Moreno A; Ross BD; Blüml S
    J Neurochem; 2001 Apr; 77(1):347-50. PubMed ID: 11279290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are astrocytes the missing link between lack of brain aspartoacylase activity and the spongiform leukodystrophy in Canavan disease?
    Baslow MH; Guilfoyle DN
    Neurochem Res; 2009 Sep; 34(9):1523-34. PubMed ID: 19319678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex: evidence that NAA functions as a molecular water pump during visual stimulation.
    Baslow MH; Hrabe J; Guilfoyle DN
    J Mol Neurosci; 2007; 32(3):235-45. PubMed ID: 17873369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Function of the N-acetyl-L-histidine system in the vertebrate eye. Evidence in support of a role as a molecular water pump.
    Baslow MH
    J Mol Neurosci; 1998 Jun; 10(3):193-208. PubMed ID: 9770642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of lithium chloride and other substances on levels of brain N-acetyl-L-aspartic acid in Canavan disease-like rats.
    Baslow MH; Kitada K; Suckow RF; Hungund BL; Serikawa T
    Neurochem Res; 2002 May; 27(5):403-6. PubMed ID: 12064356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: role in glial cell-specific signaling.
    Baslow MH
    J Neurochem; 2000 Aug; 75(2):453-9. PubMed ID: 10899919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Canavan disease, a rare early-onset human spongiform leukodystrophy: insights into its genesis and possible clinical interventions.
    Baslow MH; Guilfoyle DN
    Biochimie; 2013 Apr; 95(4):946-56. PubMed ID: 23151389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ablating N-acetylaspartate prevents leukodystrophy in a Canavan disease model.
    Guo F; Bannerman P; Mills Ko E; Miers L; Xu J; Burns T; Li S; Freeman E; McDonough JA; Pleasure D
    Ann Neurol; 2015 May; 77(5):884-8. PubMed ID: 25712859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ethanol and of alcohol dehydrogenase inhibitors on the reduction of N-acetylaspartate levels of brain in mice in vivo: a search for substances that may have therapeutic value in the treatment of Canavan disease.
    Baslow MH; Suckow RF; Hungund BL
    J Inherit Metab Dis; 2000 Nov; 23(7):684-92. PubMed ID: 11117430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAAG synthetase deficiency has only low influence on pathogenesis in a Canavan disease mouse model.
    Becker I; Wang-Eckhardt L; Eckhardt M
    J Inherit Metab Dis; 2024 Mar; 47(2):230-243. PubMed ID: 38011891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.